You are viewing the site in preview mode

Skip to main content

Table 1 Demographic Data and Clinical Features of the Groups

From: Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels

Characteristics PCOS (n = 46) PCOS + HT (n = 46) P value
Age, mean ± SD, years 26.4 ± 3.8 27.7 ± 3.2 0.072
Body mass index, mean ± SD, kg/m2 26.8 ± 5.4 27.1 ± 4.7 0.773
Waist/hip ratio, mean ± SD 0.75 ± 0.06 0.76 ± 0.07 0.737
Cigarette, n(%)
 No 22 (47.8) 25 (54.3) 0.532
 Yes 24 (52.2) 21 (45.7)
Chronic disease, n(%)
 No 39 (84.8) 29 (63) 0.060
 Asthma 5 (10.9) 7 (15.2)
 Diabetes type 2 0 2 (4.3)
 Other 2 (4.3) 8 (17.4)
Chronic Medication Use, n(%)
 No 38 (82.6) 29 (63) 0.035
 Yes 8 (17.4) 17 (37)
Menarche Age, mean ± SD, years 13 ± 1.1 13.2 ± 1.2 0.52
Menstrual Pattern, n(%)
 Regular 7 (15.3) 12 (26.1) 0.260
 Oligo/ amenorrhea 37 (80.4) 33 (71.7)
 Polymenorrhea 2 (4.3) 1 (2.2)
Acne, n(%)
 No 23 (50) 26 (56.5) 0.457
 Yes 23 (50) 19 (41.3)
Hirsutism Score (mean ± SD) 8.2 ± 4.8 8.5 ± 4.3 0.787
Fertility n(%)
 Fertile 20 (43.5) 8 (17.4) 0.007
 Pr. infertile 15 (32.6) 29 (63)
 Sec. infertile 11 (23.9) 9 (19.6)
İnfertility period, year±SD 2.2 ± 1.5 2.5 ± 2.7 0.477
Gravida 1 (0–4) 0 (0–3) < 0.001
Parity 1 (0–3) 0 (0–3) < 0.001
Abortion 0 (0–2) 0 (0–1) 0.14
Family history of autoimmune thyroiditis, n(%)
 No 35 (76.1) 20 (43.5) 0.001
 Yes 11 (23.9) 26 (56.5)
Family history of autoimmune disease, n(%)
 No 26 (56.5) 21 (45.7) 0.297
 Yes 20 (43.5) 25 (54.3)
HT period, year, median (min-max) mean ± SD 0 1.5 (0–10) 2.6 ± 2.9  
Thyroid Hormone Replacement (THR), n(%)
 No 46 (100) 20 (43.5)   < 0.001
 Yes 0 26 (56.5)  
THR time, year 0 1 (0–16) 2.1 ± 3.2  
  1. SD Standard deviation, PCOS Polycystic ovary syndrome, HT Hashimoto’s Thyroiditis
\